In the orthotopic breast cancer model around 12 % of tail injected iPSC - EPCs homed to the mammary pad region, while in the breast cancer
lung metastasis model iPSC - EPCs were distributed predominantly to the lung region.
Not exact matches
To test this idea, the researchers utilized two mouse
models of human breast cancer
metastasis and found dormant disseminated tumor cells residing upon the membrane microvasculature of
lung, bone marrow and brain tissue.
«The result was an extensive inhibition of tumor growth and prevention of
metastasis to the
lung in HER2 - positive animal
models of breast cancer,» notes Navasona Krishnan, Ph.D., a postdoctoral investigator in the Tonks lab who performed many of the experiments and is lead author on the paper reporting the results.
Their initial experiments found increased bone activity in two mouse
models of a common form of
lung cancer and in 70
lung cancer patients, even in absence of bone
metastasis.
«BMI1 plays a substantial role in many solid tumors, including one of the most aggressive
models of
lung cancer, and its expression is linked with tumor growth, invasion,
metastasis, prognosis and recurrence,» Levantini said.
Shah and his team are currently developing similar animal
models of brain
metastasis from
lung cancers and from melanoma.
Oral delivery of PND - 1186 FAK inhibitor decreases tumor growth and spontaneous breast to
lung metastasis in pre-clinical
models.
Oral administration of mebendazole in mice elicited a strong antitumor effect in a subcutaneous
model and reduced lesions in experimentally induced
lung metastasis without any toxicity when compared with paclitaxel - treated mice [9,20].
Her group has developed pre-clinical
models of metastatic disease that are used to identify genes, both in the tumour cells and in the tumour micro-environment that regulate the process of
metastasis to specific organs such as bone, liver,
lung and brain.